2 weeks Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates Zacks

Corcept (CORT) delivered earnings and revenue surprises of -29.73% and 7.08%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?